Cart
sales@molnova.com
Atractylenolide I
CAS No. 73069-13-3
Atractylenolide I( —— )
Catalog No. M19047 CAS No. 73069-13-3
Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 71 | In Stock |
|
| 10MG | 120 | In Stock |
|
| 25MG | 228 | In Stock |
|
| 50MG | 401 | In Stock |
|
| 100MG | 561 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtractylenolide I
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
-
DescriptionAtractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNF-α| IL-6
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number73069-13-3
-
Formula Weight230.3
-
Molecular FormulaC15H18O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 434.22 mM
-
SMILESCC1=C2CC3C(=C)CCCC3(C=C2OC1=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KRN-633
KRN-633 is an effective VEGFR inhibitor. The IC50s of KRN-633 for VEGFR1, VEGFR2, and VEGFR3 is 170, 160 and 125 nM, respectively.
-
Diamide
Diamide is a reagent used as a thiol oxidizing agent.
-
116-9e
116-9e (MAL2-11B) is a potent Hsp70 co-chaperone DNAJA1 inhibitor with antiviral properties, inhibiting simian virus 40 (SV40) replication, tumour antigen (TAg) endogenous ATPase activity, and TAg-mediated activation of Hsp70. 116-9e can be used to study cancer drug resistance.
